Molecular Oncology · 2007 · 94 citations · 33 references
MedicineMolecular BiologyOncologyGene ExpressionGene Expression AnalysisMetastasisCancer TranscriptomicsLymph Node MetastasisLymphatic MetastasisMalignant NeoplasmsMetastatic Breast CancerTranscriptomic ProfilingBreast Cancer GenomicsBreast Cancer Metastasis To Lymph NodesCancer Metastasis BiomarkersLymph Node MetastasesLymph Node Metastasis BiomarkersLymphatic Metastasis BiomarkersSentinel Lymph Node MetastasisTranscriptomic Heterogeneity Of Metastases
The genetic program that drives tumor metastasis and the mode and timing of its initiation are of great practical significance to clinical management. Modern technical advances open new opportunities for gaining useful relevant information. Gene expression profiles of histologically-verified viable tissue from lymph node metastases were compared with those of matched primary breast cancers from 10 different patients, among samples from over 400 cases, using high-throughput oligonucleotide arrays comprising probes for 22,000 genes. It was observed that metastases have very similar expression signatures to their parent tumors. However, detailed computational analysis revealed that a small number of genes were consistently differentially expressed between 100% of tumors and metastases, suggesting that these are mechanistically important. Lists of such candidate genes, of potential clinical interest, are provided. We interpret these results in the framework of a meta-analysis of previous investigations by others and ourselves and of existing clinical knowledge on the behavior of human tumors. The collective data show that metastases resemble their primary tumors but the signatures obtained in different studies are not sufficiently reproducible or informative to be prognostically useful, although they do give valuable insights into the pathogenesis and biology of human tumor metastasis. The findings indicate that the genetic program encoding metastasis is implemented progressively over time although, occasionally, this evolution can occur rapidly, early in the life of the neoplasm. The important clinical significance of this deduction is that, in most patients, early detection provides time for appropriate therapeutic intervention to be effective in obstructing metastasis.
33
Gene expression profiling predicts clinical outcome of breast cancer
Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text
Medicine, Bioinformatics, Oncology +17
THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.
Stephen A. Paget · The Lancet · 1889 · 5.1K citations
Medicine, Cancer Biology, Oncology +12
Histological Grading and Prognosis in Breast Cancer
H. J. G. Bloom, W Richardson · British Journal of Cancer · 1957 · 2.9K citations · Full text